Showing results (451-460 of 1,014) with videos related to

Sort By:
Pageof 102
Cancer Research Communications|January 2, 2024
Genome-wide p63-Target Gene Analyses Reveal TAp63/NRF2-Dependent Oxidative Stress ResponsesMarco Napoli, Avani A Deshpande, Deepavali Chakravarti, et al.
Cancer Research Communications|January 5, 2024
Neoadjuvant CD40 Agonism Remodels the Tumor Immune Microenvironment in Locally Advanced Esophageal/Gastroesophageal Junction CancerMaira Soto, Erin L Filbert, Hai Yang, et al.
Cancer Research Communications|December 12, 2023
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment TerminationKristen Simmons, Jane V Thomas, Kaysia Ludford, et al.
Cancer Research Communications|June 15, 2026
BRAF inhibition-associated nuclear remodeling is linked to cancer-associated fibroblast activationJie Wang, Bruna da Silva Soley, Yao Xiao, et al.
Cancer Research Communications|June 16, 2026
Development of Glypican-3-Targeting Antibody-Drug Conjugates for Hepatocellular Carcinoma TherapyNing Li, Yu Zeng, Xiaolin Xiong, et al.
Cancer Research Communications|June 16, 2026
Tumor-Associated Platelets Suppress T-Cell Function and Promote Immune Evasion in TNBC via the P-selectin/ P-selectin glycoprotein ligand-1 PathwayMargaret R Smith-Oliver, Deepa Gautam, Grace C Petrarca, et al.
Cancer Research Communications|June 24, 2026
Chemotherapy Induced Neutropenia in Palestinian Patients with Solid Malignancies: Patient Characteristics, Severity Risk Factors & Management PatternsNatalie Khamashta, Ahmad Dalal, Mo'men Alashwas, et al.
Cancer Research Communications|June 30, 2026
Association of Cumulative Proton Pump Inhibitor Use with Prostate Cancer Risk and Outcomes: A Population-Based Cohort StudyRashid K Sayyid, Raj Tiwari, Bo Zhang, et al.
Cancer Research Communications|June 26, 2026
DNA Methyltransferase Inhibition Prevents Platinum-Induced Ovarian Cancer Stem Cell EnrichmentTruc T Vuong, Riddhi Sood, Shu Zhang, et al.
Cancer Research Communications|July 31, 2026
Febuxostat enhances the anti-tumor efficacy of 2-fluoroadenine and 5'-methylthioadenosine in MTAP-deleted cancerBaiqing Tang, Hyung-Ok Lee, Daniel Krzizike, et al.
Pageof 102